Study shows using MR imaging for breast screening among women with average cancer risk improves early diagnosis.
Magnetic resonance imaging screening improves early diagnosis of breast cancer among women who are at average risk for developing breast cancer, according to a study published in Radiology.
Researchers from Germany performed a prospective observational study to investigate the utility and accuracy of breast MR imaging as a supplemental screening tool in women at average risk for breast cancer, as well as the types of cancer detected with MR imaging screening.
The study included 2,120 women who underwent 3,861 screening MR imaging studies. The women, aged 40 to 70, had no breast cancer–associated risk factors. The women with least minimal residual breast and normal conventional imaging findings were invited to undergo supplemental MR imaging screening. The outcome measures were supplemental cancer detection rates, interval cancer rates, and biologic profiles of MR imaging-detected additional cancers, as well as specificity and positive predictive value (PPV) of MR imaging screening. Tissue diagnoses or two years of follow-up were used to establish the reference standard. The study covered an observation period of 7007 women-years.
The results showed that additional cancers were found when MR imaging was used:
One cancer was diagnosed with all three methods (mammography, US, and MR imaging) during the 1,741 subsequent screening rounds and none were diagnosed with mammography only or US only, the authors wrote. They added that the cancers diagnosed with MR imaging were small, median size of 8 mm, node negative in 93.4% of cases, and dedifferentiated (high-grade cancer) in 41.7% of cases at prevalence screening and 46.0% of cases at incidence screening. No interval cancers were observed. MR imaging screening offered high specificity (97.1%) and high PPV (35.7%).
According to researchers, the results suggest that MRI can serve as a useful supplemental screening tool for women at average risk, especially those with dense mammographic tissue, and MRI is superior to supplemental ultrasound for this purpose. The results also highlight the ability of MRI in the detection of more aggressive types of cancer.
“The faster a cancer grows and the better it is in seeding metastases, the better will it be picked up early by MRI,” lead author Christiane Kuhl, MD, chair of the Department of Radiology at RWTH Aachen University in Aachen, Germany, said in a release. “In our cohort, cancers found by MRI alone exhibited features of rapid growth at pathology.”
“The interval cancer rate in our study was zero percent. Not a single cancer was undetected that became palpable,” she said. “This suggests that MRI finds breast cancers that also mammography would find, but MRI detects them earlier, and it finds the cancers which, if MRI had not been done, would have progressed to interval cancers.”
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.